Research Articles | Page 25 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis Jun 2019 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria Sep 2019 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Rationale for the Clinical Application of Flow Cytometry in Patients with Myelodysplastic Syndromes Aug 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
Rational Management Approach To Pure Red Cell Aplasia Dec 2017 Haematologica pure red cell aplasia (PRCA)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology myelodysplastic syndromes (MDS)
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents Jun 2016 J Clin Oncol myelodysplastic syndromes (MDS)
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117 May 2017 J Clin Oncol myelodysplastic syndromes (MDS)
Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes. Jun 2013 J Clin Oncol myelodysplastic syndromes (MDS)
Raising the bar for lower-risk myelodysplastic syndromes Apr 2023 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Radiation alone for solid tumors and the questionable development of therapy-related myelodysplastic syndromes Mar 2014 J Natl Cancer Inst myelodysplastic syndromes (MDS)
Share with addtoany.com.